维普中文期刊产品整合服务
41篇 您的检索式:作者名="Merlotti D"
    题名 作者 年代 出处 被引量
1Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes显示文摘Gennari L Merlotti D Valenti R 2012J Clin Endocrinol Metab2012,97,:1
2Endocrine actions of osteo- calcin显示文摘Patti A Gennari L Merlotti D 2013Int J Endoerinol2013,2013,84:1
3Serum OPG and RANKLlevels before and after intravenous is phosphonate treatment inPaget's disease of bone显示文摘Martine G Gennari L Merlotti D 2007Bone2007,40,2:1
4Prevalence of helicobacter- pylori infection in male patients with osteoporesis and controls 显示文摘Figura N Gennari L Merlotti D 2005Dig Dis Sci2005,50,5:1
5Lasofoxifene: a third- generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 显示文摘Gennari L Merlotti D Martini G 2006Expert Opin Invest Drugs2006,15,9:1
6Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development显示文摘Gennari L Merlotti D Valleggi F 2007Drugs Aging2007,24,5:1
7Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review 显示文摘Gennari L Merlotti D De-Paola V 2005Am J Epidemiol2005,161,4:1
8Aromatase activity and bone loss显示文摘GENNARI L MERLOTTI D NUTI R 2011Adv Clin Chem2011,54,:1
9estrogen receptor gene polymorphisms and the genetics of osteoporosis:a huGE review显示文摘Gennari L Merlotti D De Paola V 2005Am J Epidemiol2005,161,4:1
10Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone显示文摘Merlotti D Gennari L Martini G 2007J Bone Miner Res2007,22,:1
11Estrogen receptor gene polymorphisms and the genetics of osteoporo- sis s a HuGE review 显示文摘GENNARI L MERLOTTI D De PAOLA V 2005Am J Epidemiol2005,161,4:1
12Circulating sclerostin lev- els and bone turnover in type 1 and type 2 diabetes显示文摘Gennari L Merlotti D Valenti R 2012J Clin En- docrinolMetab2012,97,5:1
13Lasofoxifene,from the preclinicaldrug discovery to the treatment of postmenopausal osteoporosis显示文摘Gennari L Merlotti D Stolakis K 2011Expert Opin Drug Discov2011,6,2:1
14Estrogen receptor gene polymorphisms and the genetics of osteoporosis:A HuGE review 显示文摘GENNARI L MERLOTTI D PAOLA VD 2005Am J Epidemiol2005,161,:1
15Estrogen receptor gene poly- morphisms and the genetics of osteoporosis:a huge review 显示文摘Gennari L Merlotti D De Paola V 2005Am J Epidemio12005,161,4:1
16Mechanisms of impaired bone strength in type 1 and 2 diabetes 显示文摘Merlotti D Gennari L Dotta F 2010Nutr Metab Cardiovasc Dis2010,20,9:1
17Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group显示文摘Merlotti A Alterio D Vigna-Taglianti R 2014Radiat Oncol2014,9,1:1
18Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone显示文摘MARTINI G GENNARI L MERLOTTI D 2007Bone2007,40,2:1
19Professional soortac- tivity and micronutrients :Effects on bone mass显示文摘Nuti R Martini G Merlotti D 2005J En- docrinol Invest2005,28,10:1
20Aromatase activity and bone loss显示文摘Gennari L Merlotti D Nuti R 2011Adv Clin Chem2011,54,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费